x
Filter:
Filters applied
- JAH_Position_Papers
- May - November 2022Remove May - November 2022 filter
- Journal of Adolescent HealthRemove Journal of Adolescent Health filter
SAHM Position & Statement Papers
3 Results
- Position statement
Refeeding Hypophosphatemia in Hospitalized Adolescents With Anorexia Nervosa
Journal of Adolescent HealthVol. 71Issue 4p517–520Published in issue: October, 2022- The Society for Adolescent Health and Medicine
Cited in Scopus: 1Refeeding hypophosphatemia in hospitalized adolescents with anorexia nervosa is correlated with degree of malnutrition, with a high index of suspicion for severely malnourished patients (<70% median body mass index). Weight history (greater magnitude or rate of weight loss prior to admission) regardless of presentation weight has also been associated with lower serum phosphate. Higher energy meal-based refeeding starting at 2,000 kcal has not been shown to be associated with higher rates of refeeding hypophosphatemia than the traditional standard of care, lower energy refeeding. - Position paper
Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults
Journal of Adolescent HealthVol. 71Issue 5p648–654Published online: September 1, 2022- The Society for Adolescent Health and Medicine
Cited in Scopus: 1The medical provider plays an important role in the management of adolescents and young adults (AYAs) with restrictive eating disorders (EDs), including anorexia nervosa (AN), atypical anorexia nervosa, and avoidant/restrictive food intake disorder. The focus of this article is the medical management of AYAs with restrictive EDs, which can be performed by a number of different medical providers, including pediatricians, family physicians, internists, nurse practitioners, and, in some countries, psychiatrists. - Position paper
COVID Vaccines in Adolescents and Young Adults
Journal of Adolescent HealthVol. 70Issue 6p1002–1005Published in issue: June, 2022- The Society for Adolescent Health and Medicine
Cited in Scopus: 0Worldwide, a number of COVID-19 vaccines have been approved or granted Emergency Use Authorization (EUA) or Emergency Use Listing for adolescents and young adults (AYA), which has brought hope to many across the globe. Extension of the EUA for a COVID-19 vaccine to children and adolescents aged 5 through 15 years is exciting news for children, adolescents, parents, and providers of AYA. Many countries around the globe have extended immunization against COVID-19 to younger age groups. At the same time, the COVID-19 pandemic has led to a decrease globally in administration of other adolescent vaccines.
